Stock Events

Stock Events

Aktis Oncology (AKTS) Q4 2025 Earnings

3DecConfirmed

Q2 2024

Q3 2024

Q1 2025

Q4 2025

-60.17

-40.13

-20.1

-0.06

Details

Expected EPS

N/A

Actual EPS

-60.17

Surprise EPS

-60.17

Surprise Percent

+∞%

Description

Aktis Oncology (AKTS) has reported earnings of -60.17 per share for Q4 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.